Introduction
We studied the records of salivary gland tumours (SGT) held in the computer files of the Information Services Division (ISD) of the Common Services Agency of the Scottish Health Service because of the interest of one of us (BL) in both SGT and medical records. The ISD files are based on the diagnoses noted at discharge on form SMR1, an obligatory return produced for all hospital patients in Scotland. We felt that if the records proved to be accurate we might learn something about SGT; otherwise the causes of the inaccuracies would be worth knowing. Nothing so clear-cut emerged, however: the records were full of errors, but at least one statistical fact emerged that was both surprising and potentially valuable. We investigated two very different themes-namely, the incidence of SGT in Scotland, and the defects and potential value of statistics based on diagnoses at discharge. Since dealing with them separately would have necessitated much repetition, we have presented them together.
Methods
We obtained a printout from the ISD of the records of all patients discharged from Scottish hospitals during 1968-74 for whom the coded diagnoses included ICD 142 (malignant tumour of major salivary gland) or 210.20 (corresponding benign tumour). The records were listed according to the region containing the hospital-that is, according to the five regional health boards of Scotland before reorganisation-and by sex, ICD code, and date of birth; some other routine information was also included. The period 1968-74 was chosen because during these years the statistical system remained unchanged. Geographical allocation was based on hospital rather than home address, but because the former regions represented natural drainage areas to the main hospital centres the error so derived was negligible.
The accuracy of the central ISD records was assessed by comparing them with case notes and pathology-department records from hospitals in Glasgow and Aberdeen.
Results
Much miscellaneous information was obtained from the ISD print-out, but we were not satisfied that the data were reliable enough to justify study of anything other than the incidence of SGT. The table shows the numbers of admissions and of cases and the incidence of SGT in the five Scottish regions. The figures were obtained by simple count of the printout: before drawing any conclusions it was necessary to see how reliable they were.
The figures for benign and malignant cases disclosed one major error at once. The proportion of cases reported to be malignant varied from 210% in Aberdeen to 58 % in Edinburgh, but the true proportion was probably only 20 %s (British salivary gland tumour panel, unpublished data). The discrepancies were almost certainly due solely to miscoding benign SGT as malignant, an error that was widespread but varied in degree from place to place. Thus we were unable to study benign and malignant tumours separately. This did not affect the total yearly incidence, however, which was found to be 42/million population. This was three times the accepted incidence for Scotland2 and higher than that for any community except Canadian Eskimos. To discover how reliable the ISD records were, therefore, we compared them with records from two centres, one treated as outpatients or privately (a small proportion in Scotland) were omitted from the ISD record, but both groups would have appeared as false-negative cases in the laboratory figures if histology had been done. These factors tended to make our estimate too low. On the other hand, some of the-cases were recurrences of primary tumours diagnosed before 1968 and should not have been included, but recurrent tumours are not coded separately from primary ones in the ICD. Only 3 %O of the cases for which we studied case notes had been diagnosed before 1968, but this figure was lower than expected and needs confirmation. Probably these sources of error were relatively minor and to some extent cancelled each other out. Tumours of the minor salivary glands were necessarily omitted as they are coded nonspecifically in the ICD. If they had been included the estimates would have been about 10%/ higher.
Discussion
International statistics on cancer are notoriously inaccurate, yet if used with discretion may be exceedingly useful. Statistics on SGT are particularly unreliable because of doubts about their classification and particularly about the status of the most common variety, PSA (forming about 60", of the group' 3). This is now regarded as benign,' but in most earlier reports was accepted as "cancer" for statistical purposes.
Doll et a12 agreed with the findings of others' 5in regarding a yearly incidence of SGT of over 30/million as exceptional: in most countries the accepted incidence is between 5 and 15/million, that of Scotland being 14/million. The highest figures found by Doll et a1' were 36/million for Western immigrants in Israel and 34/million for Cape Province whites. Of all such figures, the ones most likely to match our own in thoroughness of ascertainment were those produced during Japanese atomicbomb studies6; an incidence of 10 cases/million was found for control populations, and 20/million for those exposed to radiation. The only reported figure that is higher than our own is that for Canadian Eskimos in their original habitat: 14 cases were found in a community of 11 500 over nine years, representing a yearly incidence of 135/million.7 Accurate assessment of this population was difficult8 but the incidence was probably genuinely high.
Our analysis apparently showed that Scotland, especially eastern Scotland, had a higher incidence of SGT than any other civilised community. Was this a genuinely high incidence or was it a product of the method of calculation ? Our method was based on returns-usually complete, though with some inaccuracies-made for every hospital admission in Scotland. Thus it is reasonable to suppose that the lower figures from other countries reflect in part an incomplete collection of cases, especially as most such collections exclude benign tumours. The Japanese figures seem to have been based on a thorough survey, however, and the incidence for Aberdeen was nearly five times that of their non-irradiated controls. Moreover, the lower (but still high) incidence among Scots who lived in the Western Region is unlikely to have been caused solely by differences in case recording. Thus the incidence of SGT in eastern Scotland is probably substantially higher than that in most other countries.
The cynical view that statistics based on diagnoses at discharge are too full of errors and too slow in appearing to be of any use is widespread among hospital medical staff, and defects are generally blamed on the computer. Something should certainly be done about the rate at which they are produced, though the troubles are due to administrative complexity rather than the computer: decentralisation is probably the answer. Nevertheless, the medical staff must themselves accept a good deal of blame for the errors. If they do not produce diagnoses quickly and accurately at discharge they should not shift responsibilities to secretaries and records clerks who try to do it for them. The coding process cannot be expected to work in the hands of even the best clerks if they have no medical supervision.
The present inaccurate statistics can be of value, however, especially if the degree and direction of inaccuracy is known. Many more uses would be possible if the input was brought up to at least 95",( accuracy. For instance, if in our study we could have been sure that all or nearly all admissions with SGT were accurately recorded in the printout, we would effectively have had an extremely cheap follow-up of all cases remaining in Scotland over the seven-year period. We would also have been able to identify recurrences. Given adequate record-linkage facilities, a modest extension of the process might indicate all readmissions of cases in which SGT was not found, which would therefore be known negatives. Deaths could also be identified. The figures so obtained would be sufficient for many purposes. If we wished, for instance, to check the recurrences, the necessary correspondence would be limited to cases in which it was likely that there was something to report. The saving on current follow-up procedures, with their great expenditure of medical and clerical time and paper, would be immense, and costs could well be reduced a hundredfold. Such follow-up would be particularly valuable in cases such as these with SGT, which are few and need to be studied over a long period. Almost any kind of follow-up could be simplified, however-so much so that one can envisage a time when it would be exceptional if any member of staff was not engaged in some form of followup in his main field of interest. There are no doubt many other uses apart from follow-up for which the diagnosis files could be used.
All this is true to only a limited extent so long as errors in coded diagnoses are as common as they are now. The major factor is the lack of active participation of medical staff. A stir of interest is needed to break the present circular impasse, in which errors in the input lead to distrust of the output and distrust of the output condones carelessness in producing the input.
Introduction
Hepatitis A is transmitted parenterally in men and non-human primates.1-' Post-transfusion hepatitis with no evidence of infection by hepatitis B virus (HBV) has thus been assumed to be caused by hepatitis A virus (HAV). Very sensitive serological techniques, however, have failed to detect any response to the HAV,4-6 suggesting that it causes few if any cases of transfusion hepatitis. We have therefore studied Greek patients with thalassaemia, who have regular blood transfusions and live in an area in which hepatitis is highly endemic, to determine the prevalence of HAV and HBV infections in such patients and evaluate the role of blood transfusion.
Patients and methods
We studied a random sample of 148 patients (81 male, 67 female) with homozygous r-thalassaemia, aged from 1 to 29 years. They had received regular blood transfusions-ranging from 7 to 351 unitssince early childhood at the Hellenic Red Cross Dracopoulion Transfusion Centre of Athens. Since 1971 all blood has been screened for HBV surface antigen (HBsAg) and all known HBsAg-positive donors
